J B Chemicals & Pharmaceuticals Ltd share price logo

J B Chemicals & Pharmaceuticals Ltd Share Price (JBCHEPHARM)

₹1408.950.17%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q1 '23 Results
Technicals
News and Events

Overview of J B Chemicals & Pharmaceuticals Ltd

Key events for J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Ltd Stock Gains Over 50% in Last Six Months - 13 Sep, 2023

    J B Chemicals & Pharmaceuticals Ltd's stock has surged over 50% in the last six months, following a stock split announcement. The company's Q1FY24 results also showed promising growth with an increase in revenue and profit.

  • Private Equity Firms Own 54% of J B Chemicals & Pharmaceuticals - 12 Sep, 2023

    KKR & Co. Inc. is the largest shareholder of J B Chemicals & Pharmaceuticals with a 54% stake, giving them significant control over the company's future. Institutions account for 25%, insiders less than 1%, and the general public holds 21%.

  • CFO Resignation at JB Chemicals and Pharmaceuticals - 08 Sep, 2023

    Lakshay Kataria, Chief Financial Officer of JB Chemicals and Pharmaceuticals, has resigned due to personal reasons. His resignation will be effective from November 30, 2023.

  • J B Chemicals & Pharmaceuticals Fixes Record Date for Stock Split - 31 Aug, 2023

    J.B. Chemicals and Pharmaceuticals has fixed September 18, 2023, as the record date for a 1:2 stock split, with each share being subdivided into two equity shares with a face value of ₹ 1 each.

  • JB Pharma Gets Clearance from USFDA for Generic Version of Sinequan - 24 Aug, 2023

    JB Chemicals & Pharmaceuticals Ltd's subsidiary, JB Pharma, receives approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Doxepin Hydrochloride Capsules, allowing production of a generic version of Pfizer's Sinequan. Stock falls slightly due to technical pullback.

  • JB Chemicals Receives FDA Approval for Generic Drug - 23 Aug, 2023

    JB Chemicals & Pharmaceuticals Ltd has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules, a generic version of Pfizer's Sinequan capsules used to treat mood disorders.

  • J B Chemicals & Pharmaceuticals CEO Divests Shares - 20 Aug, 2023

    CEO Nikhil Chopra divested ₹40m worth of shares, reducing their holding by 50%. Insider selling leaves investors cautious despite the company's profitability and growth.

  • JB Chemicals & Pharmaceuticals Declares Dividend - 17 Aug, 2023

    JB Chemicals & Pharmaceuticals Ltd has declared a dividend of Rs 9.25 per equity share with a face value of Rs 2, with the record date set as August 17.

  • JB Chemicals & Pharmaceuticals Announces Dividend - 16 Aug, 2023

    JB Chemicals & Pharmaceuticals Ltd has announced a dividend of Rs 9.25 per equity share with a face value of Rs 2, with the record date set for August 17.

  • JB Chemicals & Pharmaceuticals Records Growth in Indian Pharma Market - 14 Aug, 2023

    JB Chemicals and Pharmaceuticals saw a YoY growth of 8-11% in the Indian pharma market in July.

  • JB Chemicals & Pharmaceuticals Reports Strong Q1 Results - 10 Aug, 2023

    JB Chemicals & Pharmaceuticals Ltd reports a strong Q1 FY24 with a 35% YoY increase in net profit and 14% growth in revenue. Gross margins also expanded by 270 bps.

  • JB Chemicals & Pharmaceuticals Reports Strong Q1 Results - 09 Aug, 2023

    JB Chemicals & Pharmaceuticals Ltd reported a 35% YoY increase in Q1FY24 net profit to Rs 142 crore and a 14% YoY growth in revenue to Rs 896 crore. Domestic formulations business grew 17%, while international business crossed the Rs 400 crore mark for the first time.

  • J B Chemicals & Pharmaceuticals Increases Dividend, But Caution Advised - 03 Aug, 2023

    J. B. Chemicals & Pharmaceuticals has announced an increase in dividend to ₹9.25, but with negative free cash flows and unstable dividend history, it may not be a good income stock.

  • JB Chemicals & Pharmaceuticals Reports Strong Exports Growth and Trading at Lifetime High - 12 Jul, 2023

    JB Chemicals & Pharmaceuticals Ltd reports strong export growth to the U.S. for Q1 FY24 and trades at a lifetime high after breaking above an upwards-tiled channel with a positive MACD crossover.

  • JB Chemicals hits 5-year high after Jefferies initiates buy rating - 21 Jun, 2023

    JB Chemicals & Pharmaceuticals achieves 5-year high after Jefferies initiates buy rating. Robust product portfolio, strong R&D capabilities, and strategic acquisitions fuel growth.

  • JB Chemicals surges to record high on Jefferies' bullish view - 20 Jun, 2023

    Jefferies assigns a buy rating and a price target of Rs 2,680 per share for JB Chemicals, expecting it to outperform industry growth.

Analyst Rating for J B Chemicals & Pharmaceuticals Ltd stock

based on 12 analysts

BUY
76.92%
Buy
23.08%
Hold
0.00%
Sell

Based on 12 analysts offering long term price targets for J B Chemicals & Pharmaceuticals Ltd. An average target of ₹2740.42

Source: S&P Global Market Intelligence

J B Chemicals & Pharmaceuticals Ltd share Performance

  • ₹1401
    ₹1421.95
    ₹1408.95
    downward going graph

    0.56%

    Downside

    Day's Volatility:1.49%

    Upside

    0.92%

    downward going graph
  • ₹875
    ₹1524.5
    ₹1408.95
    downward going graph

    37.90%

    Downside

    52 Weeks Volatility:46.10%

    Upside

    8.20%

    downward going graph
1 Month Return-3.65 %
3 Month Return19.76 %
1 Year Return48.84 %
Previous Close₹1,411.30
Open₹1,418.40
Volume1.00L
Market Cap₹21,864.99Cr

J B Chemicals & Pharmaceuticals Ltd Company Information

J B Chemicals Pharmaceuticals, founded in 1976 in Maharastra, is a global player in pharmaceutical manufacturing. It manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, APIs, and agro-based products. It has subsidiaries in India and other countries and has been awarded the Certificate of Suitability to European Pharmacopoeia Monograph for Nifedipine EP from the European Directorate for Quality Medicines. It launched new products in the global market to expand its product portfolio and received approval from TGA Australia, USFDA, MCC South Africa, INVIMA Colombia, and MHRA UK. The company received the 'Most Trustworthy European Brand' by Readers Digest in cold and cough segment for the fourth consecutive year in 2003-04. It diverted into the contrast media products market during 2004-05 and entered agreements with PharmaaCare Pharmaceuticals and Ranbaxy Group for developing and marketing niche products in respective markets. It has undergone several mergers and diversifications in-order to increase its product range and profitability. More recently, it acquired a portfolio of brands from Sanzyme Private Limited and Azmarda brand from Novartis AG Switzerland. Thus, J B Chemicals Pharmaceuticals is well positioned to grow and progress further in the global pharmaceutical market.

Share Price: ₹1408.95 per share as on 28 Sep, 2023 04:01 PM
Market Capitalisation: ₹21,864.99Cr as of today
Revenue: ₹766.90Cr as on March 2023 (Q1 23)
Net Profit: ₹87.63Cr as on March 2023 (Q1 23)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
OrganisationJ B Chemicals & Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of J B Chemicals & Pharmaceuticals Ltd

Insights on J B Chemicals & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up
    img

    Foreign Institutions have increased holdings from 8.63% to 9.54% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 3 years, JBCHEPHARM stock has moved up by 176.5%

  • imgNEGATIVE IMPACT

    MF Holding Down
    img

    Mutual Funds have decreased holdings from 16.17% to 15.57% in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down
    img

    Promoters have decreased holdings from 53.93% to 53.91% in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    Profit Down
    img

    Netprofit is down for the last 3 quarters, 111.08 Cr → 87.63 Cr (in ₹), with an average decrease of 11.0% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down
    img

    Retail Investor have decreased holdings from 18.36% to 17.91% in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall
    img

    Revenue is down for the last 3 quarters, 810.78 Cr → 766.9 Cr (in ₹), with an average decrease of 2.7% per quarter

J B Chemicals & Pharmaceuticals Ltd share Valuation

J B Chemicals & Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (10.61x)

October 24, 2019

Industry (47.44x)

September 26, 2023

Today (48.68x)

September 26, 2023

Highest (51.47x)

September 14, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
Canara Robeco Conservative Hybrid Fund Direct Plan Growth OptionCanara Robeco Conservative Hybrid Fund Direct Plan Growth Option0.93%
Baroda BNP Paribas Conservative Hybrid Fund Direct Plan Growth OptionBaroda BNP Paribas Conservative Hybrid Fund Direct Plan Growth Option0.38%
Axis Retirement Savings Fund - Conservative Plan Direct GrowthAxis Retirement Savings Fund - Conservative Plan Direct Growth1.9%

J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
53.91%
-0.05
Foreign Institutions
9.54%
10.56
Mutual Funds
15.57%
-3.72
Retail Investors
17.91%
-2.43
Others
3.08%
5.64

Technicals of J B Chemicals & Pharmaceuticals Ltd share

News & Events of J B Chemicals & Pharmaceuticals Ltd

Frequently Asked Questions

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price today is ₹1408.95

  • Today’s highest price of J B Chemicals & Pharmaceuticals Ltd is ₹1421.95.
  • Today’s lowest price of J B Chemicals & Pharmaceuticals Ltd is ₹1401.

Today’s traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 1.00L.

Today’s market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹21864.99Cr.

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARMPrice
52 Week High
₹1524.5
52 Week Low
₹875

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1408.95. It is down -7.58% from its 52 Week High price of ₹1524.5

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1408.95. It is up 61.02% from its 52 Week Low price of ₹875

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARMReturns
1 Day Returns
-2.35%
1 Month Returns
-3.65%
3 Month Returns
19.76%
1 Year Returns
48.84%